Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8 a phase 2 metabolite as perpetrator of drug-drug interactions.

Added 2277 days ago (28.06.2014)
Authors: Tornio A, Filppula A, Kailari O, Neuvonen M, Nyrönen T, Tapaninen T, Neuvonen P, Niemi M, Backman J
PubMed id: 24971633
Read article